the patients had hypertension (diastolic blood pressure > 95 mm Hg), ischaemic heart disease, asthma, respiratory failure, or thyrotoxicosis or was alcoholic. All patients yielded normal results to liver function tests. All gave informed written consent to the study, which was approved by the hospital research committee.
Before endoscopy respiratory rate and blood pressure were recorded and expired minute ventilation measured with a Wright's respirometer attached to a closely fitting anaesthetic face mask. The orientation and cognitive function of each patient were tested by standardised questions regarding place and time, and simple mental arithmetic; the patient's overall state of alertness was evaluated and recorded on a 10 cm horizontal visual analogue scale ranging from totally unresponsive (0 cm) to fully alert (10 cm). All evaluations were made by the same physician and sealed in separate envelopes to prevent comparisons during the study.
Another physician administered diazepam by slow intravenous injection until sedation and relaxation were produced as indicated by drooping of the patient's eyelids, dysarthria, generalised muscle relaxation, and ability to swallow the gastroscope. After endoscopy measurements of alertness, ventilation, and blood pressure were repeated. Each patient was then randomly assigned to receive by bolus intravenous injection either 100 mg doxapram or an identical placebo; assessments were repeated five, 60, and 120 minutes later.
Data were analysed by paired t test, x2 test, or Fisher's exact test. Before diazepam all 115 patients were orientated and 113 could make a satisfactory attempt at mental arithmetic. After diazepam 24 became unexpectedly heavily sedated (visual analogue scale < 5 cm). There were no significant differences in dose of diazepam (mean 26-0 mg), age, weight, height, liver function, or concurrent medication between patients who became heavily or lightly sedated.
Of the 24 heavily sedated patients, 13 received doxapram and 11 placebo. There was a highly significant improvement compared with placebo five minutes after doxapram was given: the number of patients orientated increased from three to nine (p < 0 0001), the number able to attempt mental arithmetic from three to 10 (p < 00001), and the mean visual analogue score from 2 to 7 cm (p < 0-001). None of the measurements after placebo changed.
A mean increase in ventilation of 1-7 1/min (p < 0 001) occurred in patients who received doxapram, but there was no change in ventilation in those given placebo.
Sixty minutes after injection of doxapram ventilation had fallen to values seen before injection and was similar in heavily sedated patients who had received doxapram and those who had received placebo. However, the level of alertness of the heavily sedated patients who had received doxapram did not fall ( figure) ; the proportion orientated, the number able to do arithmetic, and the mean visual analogue score were the same as at five minutes. During the elapsed time the alertness of the placebo-treated patients had increased, so the difference between the two groups was not significant. 
Comment
It is essential, when considering the prevalence of resistance, to compare like with like; only normally susceptible Gram negative urinary pathogens were included in this survey, the laboratory techniques were unchanged, the same period was studied each year, and there were no outbreaks of hospital cross infection during the study periods. Inevitably such figures, especially those for hospital patients, must include more than one isolation from some patients, but this factor is not likely to vary from year to year. (821) 13 (794) 12 (847) 19 ( It appears that a plateau of resistance had been reached by 1979
(before trimethoprim was available alone). Our figure of 12','o is in broad agreement with those from other centres in Great Britain at that time,2 and suggests that the routine laboratory method used provides reasonably accurate results. In any case the method has not changed, and therefore the change in the findings is likely to be a true one. One must wonder whether this sharp rise in resistance is related to the increasing use of trimethoprim alone. As a result of our experience with the emergence of Staphylococcus epidermidis infection in patients with catheters who were treated with trimethoprim4 we have encouraged the use of co-trimoxazole in hospital. (Figures from this hospital pharmacy show that the ratio of the use of co-trimoxazole to trimethoprim is 16:1.) Trimethoprim has been widely promoted in general practice, however, where the level of resistance has more than doubled during the past year. Clearly in those hospitals which serve a local population there must be some overlap between hospital and general practice patients, and the rise in hospital resistance, after a plateau for three years, may be related to the use of trimethoprim in general practice. Furthermore, most of the increasing number of isolates resistant to trimethoprim but sensitive to sulphonamide came from general practice.
Lacey has recently reported no change in the level of resistance of E coli to trimethoprim in the hospitals of the King's Lynn Health District, where co-trimoxazole was completely replaced by trimethoprim in 1980.-His study concluded in January 1982 and did not include Gram negative pathogens other than E coli. His figures are therefore not comparable with the figures reported here.
Co-trimoxazole has been a highly effective agent for treatment of urinary infection for the past 14 years; if the use of trimethoprim alone is now resulting in increased resistance it is important that this should be recognised. Anonymous. Bacterial resistance to trimethoprirrn [Editorial] . 
Case reports
Case 1-A 75 year old woman presented with stage IVB mixed cellularity Hodgkin's disease affecting the liver and a fever of 38'!C. Bacteriological investigations gave negative results and chemotherapy was started with 10 mg vinblastine intravenously on day 1 followed by 14 days of chlorambucil 10 mg daily, prednisolone 40 mg daily, and procarbazine 50 mg thrice daily. On day 2 her temperature fell from 38`C to 35"C and on day 3 her rectal temperature was 34''C and remained low for 10 days (figure). Further chemotherapy with vinblastine and prednisolone was not associated with hypothermia.
Case 2-A 36 year old man presented with stage IVB mixed cellularity Hodgkin's disease in relapse. He had received outpatient chemotherapy with the same regimen as case 1, but relapsed one month after completing treatment, with sustained fever, lymphadenopathy, and liver enlargement. Chemotherapy was restarted with intravenous infusion of 30 mg doxorubicin, 10 mg bleomycin, 8 mg vinblastine, and methotrexate 250 mg/M2 on day 1, with prednisolone 50 mg daily. His temperature, 38-5"C on admission, fell to 34 C and remained low for four days (figure). Unfortunately, six weeks after chemotherapy, he developed chickenpox and died with disseminated varicella infection. Necropsy showed hepatic Hodgkin's disease.
Case 
Comment
Spontaneous hypothermia in Hodgkin's disease is rare.' Some patients with Hodgkin's disease develop hypothermia after administration of salicylates,2 but none of our patients received these. There is one report of hypothermia in Hodgkin's disease after chemotherapy with mustine and vinblastine,3 but the cytotoxics used here differed slightly and only vinblastine and prednisolone were common to all patients: hypothermia is not a recognised side effect of any of these drugs. Case 3 was later found to have intracerebral Hodgkin's disease, which could have affected hypothalamic function, but she was otherwise similar to the other patients.
The cause of fever in Hodgkin's disease in the absence of infection is unknown. Experiments have shown that a substance, "endogenous pyrogen," is produced by Kupffer's cells in rabbits in response to endotoxin. This is also produced in vitro by lymphoid tissue from
